BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hinder LM, Murdock BJ, Park M, Bender DE, O'Brien PD, Rumora AE, Hur J, Feldman EL. Transcriptional networks of progressive diabetic peripheral neuropathy in the db/db mouse model of type 2 diabetes: An inflammatory story. Exp Neurol 2018;305:33-43. [PMID: 29550371 DOI: 10.1016/j.expneurol.2018.03.011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Savelieff MG, Feldman EL. Immune-mediated vincristine-induced neuropathy: Unlocking therapies. J Exp Med 2021;218:e20210286. [PMID: 33751022 DOI: 10.1084/jem.20210286] [Reference Citation Analysis]
2 Aghamiri SH, Komlakh K, Ghaffari M. The crosstalk among TLR2, TLR4 and pathogenic pathways; a treasure trove for treatment of diabetic neuropathy. Inflammopharmacology 2022. [PMID: 35020096 DOI: 10.1007/s10787-021-00919-3] [Reference Citation Analysis]
3 Stino AM, Rumora AE, Kim B, Feldman EL. Evolving concepts on the role of dyslipidemia, bioenergetics, and inflammation in the pathogenesis and treatment of diabetic peripheral neuropathy. J Peripher Nerv Syst. 2020;25:76-84. [PMID: 32412144 DOI: 10.1111/jns.12387] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
4 Krajnak K. Vibrotactile sensitivity testing for occupational and disease-induce peripheral neuropathies. J Toxicol Environ Health B Crit Rev 2021;24:162-72. [PMID: 33719930 DOI: 10.1080/10937404.2021.1897911] [Reference Citation Analysis]
5 Hinder LM, Sas KM, O'Brien PD, Backus C, Kayampilly P, Hayes JM, Lin CM, Zhang H, Shanmugam S, Rumora AE, Abcouwer SF, Brosius FC 3rd, Pennathur S, Feldman EL. Mitochondrial uncoupling has no effect on microvascular complications in type 2 diabetes. Sci Rep 2019;9:881. [PMID: 30696927 DOI: 10.1038/s41598-018-37376-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
6 Gonçalves NP, Jager SE, Richner M, Murray SS, Mohseni S, Jensen TS, Vaegter CB. Schwann cell p75 neurotrophin receptor modulates small fiber degeneration in diabetic neuropathy. Glia 2020;68:2725-43. [PMID: 32658363 DOI: 10.1002/glia.23881] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Hagen KM, Ousman SS. Aging and the immune response in diabetic peripheral neuropathy. J Neuroimmunol 2021;355:577574. [PMID: 33894676 DOI: 10.1016/j.jneuroim.2021.577574] [Reference Citation Analysis]
8 Eid SA, O'Brien PD, Hinder LM, Hayes JM, Mendelson FE, Zhang H, Narayanan S, Abcouwer SF, Brosius FC 3rd, Pennathur S, Savelieff MG, Feldman EL. Differential effects of minocycline on microvascular complications in murine models of type 1 and type 2 diabetes. J Transl Sci 2021;7. [PMID: 33868719 DOI: 10.15761/jts.1000431] [Reference Citation Analysis]
9 Eid SA, Hinder LM, Zhang H, Eksi R, Nair V, Eddy S, Eichinger F, Park M, Saha J, Berthier CC, Jagadish HV, Guan Y, Pennathur S, Hur J, Kretzler M, Feldman EL, Brosius FC. Gene expression profiles of diabetic kidney disease and neuropathy in eNOS knockout mice: Predictors of pathology and RAS blockade effects. FASEB J 2021;35:e21467. [PMID: 33788970 DOI: 10.1096/fj.202002387R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 McGregor BA, Eid S, Rumora AE, Murdock B, Guo K, de Anda-Jáuregui G, Porter JE, Feldman EL, Hur J. Conserved Transcriptional Signatures in Human and Murine Diabetic Peripheral Neuropathy. Sci Rep 2018;8:17678. [PMID: 30518872 DOI: 10.1038/s41598-018-36098-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
11 Luo Q, Feng Y, Xie Y, Shao Y, Wu M, Deng X, Yuan WE, Chen Y, Shi X. Nanoparticle-microRNA-146a-5p polyplexes ameliorate diabetic peripheral neuropathy by modulating inflammation and apoptosis. Nanomedicine 2019;17:188-97. [PMID: 30721753 DOI: 10.1016/j.nano.2019.01.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
12 Elzinga S, Murdock BJ, Guo K, Hayes JM, Tabbey MA, Hur J, Feldman EL. Toll-like receptors and inflammation in metabolic neuropathy; a role in early versus late disease? Exp Neurol 2019;320:112967. [PMID: 31145897 DOI: 10.1016/j.expneurol.2019.112967] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
13 Guo K, Eid SA, Elzinga SE, Pacut C, Feldman EL, Hur J. Genome-wide profiling of DNA methylation and gene expression identifies candidate genes for human diabetic neuropathy. Clin Epigenetics 2020;12:123. [PMID: 32787975 DOI: 10.1186/s13148-020-00913-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
14 Fan B, Chopp M, Zhang ZG, Liu XS. Treatment of diabetic peripheral neuropathy with engineered mesenchymal stromal cell-derived exosomes enriched with microRNA-146a provide amplified therapeutic efficacy. Exp Neurol 2021;341:113694. [PMID: 33727097 DOI: 10.1016/j.expneurol.2021.113694] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Cho NR, Yu Y, Oh CK, Ko DS, Myung K, Lee Y, Na HS, Kim YH. Neuropeptide Y: a potential theranostic biomarker for diabetic peripheral neuropathy in patients with type-2 diabetes. Ther Adv Chronic Dis 2021;12:20406223211041936. [PMID: 34729143 DOI: 10.1177/20406223211041936] [Reference Citation Analysis]
16 Leal-Julià M, Vilches JJ, Onieva A, Verdés S, Sánchez Á, Chillón M, Navarro X, Bosch A. Proteomic quantitative study of dorsal root ganglia and sciatic nerve in type 2 diabetic mice. Mol Metab 2021;55:101408. [PMID: 34856394 DOI: 10.1016/j.molmet.2021.101408] [Reference Citation Analysis]
17 Eid S, Sas KM, Abcouwer SF, Feldman EL, Gardner TW, Pennathur S, Fort PE. New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism. Diabetologia. 2019;62:1539-1549. [PMID: 31346658 DOI: 10.1007/s00125-019-4959-1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 56] [Article Influence: 16.0] [Reference Citation Analysis]
18 Eid SA, Feldman EL. Advances in diet-induced rodent models of metabolically acquired peripheral neuropathy. Dis Model Mech 2021;14:dmm049337. [PMID: 34762126 DOI: 10.1242/dmm.049337] [Reference Citation Analysis]
19 Guo K, Elzinga S, Eid S, Figueroa-Romero C, Hinder LM, Pacut C, Feldman EL, Hur J. Genome-wide DNA methylation profiling of human diabetic peripheral neuropathy in subjects with type 2 diabetes mellitus. Epigenetics 2019;14:766-79. [PMID: 31132961 DOI: 10.1080/15592294.2019.1615352] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
20 Takeshita Y, Sato R, Kanda T. Blood-Nerve Barrier (BNB) Pathology in Diabetic Peripheral Neuropathy and In Vitro Human BNB Model. Int J Mol Sci 2020;22:E62. [PMID: 33374622 DOI: 10.3390/ijms22010062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Park M, Kwon CH, Ha HK, Han M, Song SH. RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney. BMC Nephrol 2020;21:398. [PMID: 32977749 DOI: 10.1186/s12882-020-02025-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
22 Richner M, Ferreira N, Dudele A, Jensen TS, Vaegter CB, Gonçalves NP. Functional and Structural Changes of the Blood-Nerve-Barrier in Diabetic Neuropathy. Front Neurosci 2018;12:1038. [PMID: 30692907 DOI: 10.3389/fnins.2018.01038] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 11.3] [Reference Citation Analysis]
23 Tu Y, Chen Z, Zhang F, Di Z, Zhang J, Cai L. Gene Expression Profiling of the Sciatic Nerve in Streptozotocin-Induced Diabetic Rats with Peripheral Neuropathy. J Diabetes Res 2020;2020:5283284. [PMID: 32566679 DOI: 10.1155/2020/5283284] [Reference Citation Analysis]
24 Essmat A, Hussein MS. Green tea extract for mild-to-moderate diabetic peripheral neuropathy A randomized controlled trial. Complement Ther Clin Pract 2021;43:101317. [PMID: 33517103 DOI: 10.1016/j.ctcp.2021.101317] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Savelieff MG, Callaghan BC, Feldman EL. The emerging role of dyslipidemia in diabetic microvascular complications. Curr Opin Endocrinol Diabetes Obes 2020;27:115-23. [PMID: 32073426 DOI: 10.1097/MED.0000000000000533] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
26 Calcutt NA. Diabetic neuropathy and neuropathic pain: a (con)fusion of pathogenic mechanisms? Pain 2020;161:S65-86. [PMID: 32999525 DOI: 10.1097/j.pain.0000000000001922] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
27 Fan B, Li C, Szalad A, Wang L, Pan W, Zhang R, Chopp M, Zhang ZG, Liu XS. Mesenchymal stromal cell-derived exosomes ameliorate peripheral neuropathy in a mouse model of diabetes. Diabetologia. 2020;63:431-443. [PMID: 31740984 DOI: 10.1007/s00125-019-05043-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 41] [Article Influence: 10.3] [Reference Citation Analysis]